Position in MRKR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,013
-$8,199 QoQ
Shares Held
11,574
-59.1% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 35 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRKR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Virtu Financial LLC holds $37,870,510 across 148 Biotechnology names. MRKR ranks #120 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
58,459 | $4,130,128 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
29,790 | $3,954,026 | |
| 3 | ABVX |
Abivax S.A.
|
19,155 | $2,552,595 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
9,220 | $2,256,779 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
12,556 | $1,439,796 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
8,163 | $1,000,620 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
17,524 | $962,768 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
221,500 | $921,440 |
All Filings in MRKR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,013 | 11,574 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $25,212 | 28,329 | Shares | Defined | 2025-11-14 | |
| 2023-06-30 | $63,463 | 20,472 | Shares | Defined | 2023-07-27 | |
| 2022-09-30 | $7,401 | 20,004 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $5,446 | 16,506 | Shares | Defined | 2022-08-09 | |
| 2021-12-31 | $12,382 | 13,034 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $76,622 | 45,339 | Shares | Defined | 2021-11-12 | |
| 2020-12-31 | $110,523 | 76,223 | Shares | Defined | 2021-02-24 | |
| 2020-09-30 | $63,340 | 42,227 | Shares | Defined | 2020-12-11 | |
| 2020-06-30 | $25,500 | 12,319 | Shares | Defined | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||